Our Target Validation service is designed to rigorously test and confirm the viability of

specific proteinsas CNS drug targets using advanced in vivo electrophysiology.

 

Our methodologies are supported by decades of experience in neuropharmacology,

genetic mouse models, viral gene transfer, and recordings of neurons and local field

potentials in behaving rodents.

 

This comprehensive approach provides detailed insights into the function of potential

molecular targets within brain circuits that support specific cognitive, emotional, and

motivational processes. These predictive insights are crucial in the initial stages

of drug discovery, ensuring that only the most promising targets are pursued in

subsequent development phases and significantly contributing to their success.